Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

about

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

Item

http://www.wikidata.org/entity/Q55016620

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

@en

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

@nl

type

Item

label

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

@en

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

@nl

prefLabel

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

@en

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

@nl

P1476

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

@en

P2093

Robert E Olivo

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphate control in end-stage renal disease: barriers and opportunities

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D

Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.

Intracellular Phosphate Dynamics in Muscle Measured by Magnetic Resonance Spectroscopy during Hemodialysis.

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.

P304

868-870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2215/CJN.04380417

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Julia J Scialla

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28550079

http://www.w3.org/2001/XMLSchema#string

P932

5460702

http://www.w3.org/2001/XMLSchema#string